698 related articles for article (PubMed ID: 16573260)
1. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
Ajith C; Gupta S; Kanwar AJ
J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
[TBL] [Abstract][Full Text] [Related]
2. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
[TBL] [Abstract][Full Text] [Related]
3. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
[TBL] [Abstract][Full Text] [Related]
4. Alopecia areata: a long term follow-up study of 191 patients.
Tosti A; Bellavista S; Iorizzo M
J Am Acad Dermatol; 2006 Sep; 55(3):438-41. PubMed ID: 16908349
[TBL] [Abstract][Full Text] [Related]
5. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
6. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
Miranda A; Mato F; Quiñones PA
Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
[TBL] [Abstract][Full Text] [Related]
7. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
Nakajima T; Inui S; Itami S
Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
9. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
10. [Topical therapy of alopecia areata with squaric acid dibutyl ester].
Morishita M; Nagai T; Sato Y
Nihon Hifuka Gakkai Zasshi; 1987 Jan; 97(1):61-4. PubMed ID: 3573366
[No Abstract] [Full Text] [Related]
11. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
12. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
13. Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
Chen CA; Carlberg V; Kroshinsky D
Pediatr Dermatol; 2017 Jan; 34(1):e44-e46. PubMed ID: 27699860
[TBL] [Abstract][Full Text] [Related]
14. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
15. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
Losol E; Şentürk N
Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
[TBL] [Abstract][Full Text] [Related]
16. Treatment of persistent alopecia areata with sulfasalazine.
Rashidi T; Mahd AA
Int J Dermatol; 2008 Aug; 47(8):850-2. PubMed ID: 18717871
[TBL] [Abstract][Full Text] [Related]
17. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
[TBL] [Abstract][Full Text] [Related]
18. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical sensitizers in the treatment of alopecia areata.
Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
[TBL] [Abstract][Full Text] [Related]
20. Modified immunotherapy for alopecia areata.
Yoshimasu T; Furukawa F
Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
